Pharm'Up

AKTU – B. Pharm. 4th Semester (Second Year)

1 min read

• Previous Papers

AKTU – B. Pharm. 4th Semester (Second Year)

Pharm'Up

BP401T Pharmaceutical Organic Chemistry III– Theory Pharmaceutical Organic Chemistry III (BP401T) MAY-2025 BP402T Medicinal Chemistry I –...

Read More Read more about AKTU – B. Pharm. 4th Semester (Second Year)

AKTU – B. Pharm. 3rd Semester (Second Year)

1 min read

• Previous Papers

AKTU – B. Pharm. 3rd Semester (Second Year)

Pharm'Up

PHARMACEUTICAL ORGANIC CHEMISTRY-II – Theory (BP301T) Pharmaceutical Organic Chemistry II – Theory MAY-2025 BP301T Pharmaceutical Organic Chemistry...

Read More Read more about AKTU – B. Pharm. 3rd Semester (Second Year)

New MRI Technique Maps Brain Metabolism to Detect Neurological Disease Signatures

2 min read

• Pharma News

New MRI Technique Maps Brain Metabolism to Detect Neurological Disease Signatures

Pharm'Up

In a major advancement for brain imaging, scientists at the University of Illinois Urbana-Champaign have developed a...

Read More Read more about New MRI Technique Maps Brain Metabolism to Detect Neurological Disease Signatures

BACE1 Protein Unlocks New Treatment Potential for Lung Cancer Brain Metastasis

3 min read

• Pharma News

BACE1 Protein Unlocks New Treatment Potential for Lung Cancer Brain Metastasis

Pharm'Up

In a groundbreaking scientific advancement, a collaborative team from McMaster University, Cleveland Clinic, and the Case Comprehensive...

Read More Read more about BACE1 Protein Unlocks New Treatment Potential for Lung Cancer Brain Metastasis

RINVOQ Delivers Hopeful Outcomes in Alopecia Areata Study

1 min read

• Industries

RINVOQ Delivers Hopeful Outcomes in Alopecia Areata Study

Pharm'Up

AbbVie has released encouraging topline results from Study 2 of the Phase 3 UP-AA clinical program, assessing...

Read More Read more about RINVOQ Delivers Hopeful Outcomes in Alopecia Areata Study

FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment

2 min read

• Industries

FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment

Pharm'Up

LENZ Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted approval for...

Read More Read more about FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment

AKTU – B. Pharm. 2nd Semester (First Year)

1 min read

• Previous Papers

AKTU – B. Pharm. 2nd Semester (First Year)

Pharm'Up

HUMAN ANATOMY AND PHYSIOLOGY-II THEORY (BP201T) HUMAN-ANATOMY-AND-PHYSIOLOGY-II (BP201T) MAY-2025 BP201T Human Anatomy and Physiology II – Theory...

Read More Read more about AKTU – B. Pharm. 2nd Semester (First Year)

Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

3 min read

• Pharma News

Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

Pharm'Up

Merck has revealed that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review...

Read More Read more about Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

2 min read

• Industries

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Pharm'Up

Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...

Read More Read more about Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market

1 min read

• Industries

Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market

Pharm'Up

Global pharmaceutical leader Lupin Limited has unveiled the launch of Ipratropium Bromide Nasal Solution (Nasal Spray) in...

Read More Read more about Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market